{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9220185",
  "DateCompleted": {
    "Year": "1997",
    "Month": "09",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "02",
    "Day": "25"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0160-9289",
      "JournalIssue": {
        "Volume": "20",
        "Issue": "7",
        "PubDate": {
          "Year": "1997",
          "Month": "Jul"
        }
      },
      "Title": "Clinical cardiology",
      "ISOAbbreviation": "Clin Cardiol"
    },
    "ArticleTitle": "Propafenone-induced drug fever in the absence of agranulocytosis.",
    "Pagination": {
      "StartPage": "662",
      "EndPage": "664",
      "MedlinePgn": "662-4"
    },
    "Abstract": {
      "AbstractText": [
        "Propafenone is an antiarrhythmic drug used in the treatment of life-threatening ventricular tachyarrhythmias. Adverse reactions necessitating discontinuation of the medication are common. Propafenone-induced drug fever has not been definitively proven. We present a case report of drug fever secondary to propafenone, confirmed with rechallenge."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA."
          }
        ],
        "LastName": "O'Rourke",
        "ForeName": "D J",
        "Initials": "DJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Palac",
        "ForeName": "R T",
        "Initials": "RT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Holzberger",
        "ForeName": "P T",
        "Initials": "PT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gerling",
        "ForeName": "B R",
        "Initials": "BR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Greenberg",
        "ForeName": "M L",
        "Initials": "ML"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Cardiol",
    "NlmUniqueID": "7903272",
    "ISSNLinking": "0160-9289"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Arrhythmia Agents"
    },
    {
      "RegistryNumber": "68IQX3T69U",
      "NameOfSubstance": "Propafenone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Agranulocytosis"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Arrhythmia Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnosis, Differential"
    },
    {
      "QualifierName": [
        "blood",
        "chemically induced",
        "diagnosis"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Leukocyte Count"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Propafenone"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Tachycardia, Ventricular"
    }
  ]
}